%0 Journal Article %A Paulo Cardoso Lins-Filho %A Thuanny Silva de Macêdo %A Andressa Kelly Alves Ferreira %A Maria Cecília Freire de Melo %A Millena Mirella Silva de Araújo %A Jaciel Leandro de Melo Freitas %A Thaise Urbano Caldas %A Arnaldo de França Caldas, Jr %T Assessing the quality, readability and reliability of online information on COVID-19: an infoveillance observational study %D 2020 %R 10.1101/2020.05.30.20117614 %J medRxiv %P 2020.05.30.20117614 %X Objective This study aimed to assess the quality, reliability and readability of internet-based information on COVID-19 available on Brazil’ most used search engines.Methods A total of 68 websites were selected through Google, Bing, and Yahoo. The websites content quality and reliability were evaluated using the DISCERN questionnaire, the Journal of American Medical Association (JAMA) benchmark criteria, and the presence of the Health on Net (HON) certification. Readability was assessed by the Flesch Reading Ease adapted to Brazilian Portuguese (FRE-BP).Results The web contents were considered moderate to low quality according to DISCERN and JAMA mean scores. Most of the sample presented very difficult reading levels and only 7.4% displayed HON certification. Websites of Governmental and health-related authorship nature showed lower JAMA mean scores and quality and readability measures did not correlate to the webpages content type.Conclusion COVID-19 related contents available online were considered of low to moderate quality and not accessible.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe database is available. %U https://www.medrxiv.org/content/medrxiv/early/2020/05/30/2020.05.30.20117614.full.pdf